@article{af330ed22929446a865df229dd5cbce3,
title = "Asbestos diseases research institute – a new who collaborating center",
author = "Ken Takahashi",
note = "Funding Information: In the clinical area, ADRI aspires to translate laboratory research findings to the clinical setting. Many of our grant applications are integrated in the context of translational research, working to move ideas “from the bench to the bedside.” ADRI{\textquoteright}s patient support activities have a strong clinical focus, with two professional registered nurses providing clinical knowledge and social support to mesothelioma patients, families, and carers. This activity has gained nationwide recognition and sustained financial support from the Dust Diseases Authority of the state of New South Wales (NSW). It is important to note that ADRI{\textquoteright}s patient support activities cut across the area of public health/prevention as well, with an important emphasis on advocacy and increasing awareness towards ARDs. Funding Information: The international cooperation of the Asbestos Diseases Research Institute, including the writing of this manuscript, is funded by the Regional Collaborations Program of the Australian Academy of Science (2019–2020), the Karen Howard Grant (2020–2021) and the United Nations Environment Programme (2021).",
year = "2021",
doi = "10.2486/indhealth.1-3",
language = "English",
volume = "59",
pages = "143--145",
journal = "Industrial Health",
issn = "0019-8366",
publisher = "National Institute of Industrial Health",
number = "3",
}